C. V. van Baalen

发表

Selective in vitro expansion of HLA class I‐restricted HIV‐1 Gag‐specific CD8 + T cells: cytotoxic T‐lymphocyte epitopes and precursor frequencies

F. Miedema, A. Osterhaus, A. Geretti, 1993, AIDS.

Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition

A. Osterhaus, V. Cerundolo, R. V. Van BInnendijk, 1992, The Journal of experimental medicine.

Decline of simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in the peripheral blood of long-term nonprogressing macaques infected with SIVmac32H-J5.

A. Osterhaus, G. van Amerongen, S. Norley, 1999, The Journal of infectious diseases.

Mechanism of Antiviral Activity of Nitazoxanide against the Influenza Virus: Effect of Tizoxanide on AdenosineTriphosphate in Influenza-virus Infected Madin Darby Canine Kidney Cells

A. Tijsma, J. Rossignol, C. V. van Baalen, 2021, bioRxiv.

Vaccination with Rev and Tat against AIDS.

A. Osterhaus, G. van Amerongen, G. Sutter, 1999, Vaccine.

The choice of antigen for therapeutic immunization against AIDS.

A. Osterhaus, K. Stittelaar, C. Guillon, 2002, Trends in immunology.

Annual Vaccination against Influenza Virus Hampers Development of Virus-Specific CD8+ T Cell Immunity in Children

A. Osterhaus, H. Tiddens, G. Rimmelzwaan, 2011, Journal of Virology.

Characterization of the Human CD8+ T Cell Response following Infection with 2009 Pandemic Influenza H1N1 Virus

A. Osterhaus, M. Koopmans, G. Rimmelzwaan, 2011, Journal of Virology.

Ferrets as a Novel Animal Model for Studying Human Respiratory Syncytial Virus Infections in Immunocompetent and Immunocompromised Hosts

A. Osterhaus, G. van Amerongen, E. van der Vries, 2016, Viruses.

Kinetics of Antiviral Activity by Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes (CTL) and Rapid Selection of CTL Escape Virus In Vitro

M. Schutten, C. Baalen, P. Boers, 1998, Journal of Virology.

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption.

P. Eilers, A. Osterhaus, J. Aerts, 2012, Clinical immunology.

Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity.

A. Osterhaus, G. Rimmelzwaan, G. de Mutsert, 2005, The Journal of infectious diseases.

Cross-Recognition of Avian H5N1 Influenza Virus by Human Cytotoxic T-Lymphocyte Populations Directed to Human Influenza A Virus

A. Osterhaus, G. Rimmelzwaan, R. Fouchier, 2008, Journal of Virology.

Construction and characterisation of infectious recombinant HIV-1 clones containing CTL epitopes from structural proteins in Nef.

A. Osterhaus, C. Guillon, E. Verschuren, 2002, Journal of virological methods.

A Single Immunization with CoVaccine HT-Adjuvanted H5N1 Influenza Virus Vaccine Induces Protective Cellular and Humoral Immune Responses in Ferrets

T. Kuiken, A. Osterhaus, G. Rimmelzwaan, 2010, Journal of Virology.

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

H. Schuitemaker, R. Bende, F. Miedema, 1995, The Journal of experimental medicine.

Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.

F. Miedema, A. Osterhaus, F. de Wolf, 1997, The Journal of general virology.

The loss of immunodominant epitopes affects interferon‐γ production and lytic activity of the human influenza virus‐specific cytotoxic T lymphocyte response in vitro

A. Osterhaus, G. Rimmelzwaan, R. Fouchier, 2007 .

Comparison of the efficacy of early versus late viral proteins in vaccination against SIV.

A. Osterhaus, G. van Amerongen, G. Sutter, 2002, Vaccine.

The advantage of early recognition of HIV-infected cells by cytotoxic T-lymphocytes.

A. Osterhaus, R. Gruters, C. V. van Baalen, 2002, Vaccine.

HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption

P. Lemey, A. Osterhaus, J. Aerts, 2013, AIDS.

Macrophage Tropism of Human Immunodeficiency Virus Type 1 Facilitates In Vivo Escape from Cytotoxic T-Lymphocyte Pressure

A. Osterhaus, M. Schutten, C. Guillon, 2001, Journal of Virology.

Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M158-66 Epitope-Specific CD8+ T Lymphocytes

G. Rimmelzwaan, R. Fouchier, C. E. van de Sandt, 2018, Journal of Virology.

The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2

Soo-Young Lee, M. Song, Jung-ah Choi, 2021, Biochemical and Biophysical Research Communications.

Therapeutic efficacy of CT-P59 against P.1 variant of SARS-CoV-2

Soo-Young Lee, M. Song, Jung-ah Choi, 2021, bioRxiv.

Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant

P. Moore, Y. Choi, Soo-Young Lee, 2021, bioRxiv.

Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1.

F. Miedema, A. Osterhaus, A. Geretti, 1996, The Journal of general virology.

CD8+ cytotoxic T lymphocytes of a cynomolgus macaque infected with simian immunodeficiency virus (SIV) mac32H-J5 recognize a nine amino acid epitope in SIV Gag p26.

A. Osterhaus, G. van Amerongen, A. Geretti, 1997, Journal of General Virology.

Preservation of phenotype and function of positively selected virus-specific CD8+ T lymphocytes following anti-Fab detachment from immunomagnetic beads.

A. Osterhaus, A. Geretti, M. Poelen, 1993, Journal of immunological methods.

Detection of Nonhemagglutinating Influenza A(H3) Viruses by Enzyme-Linked Immunosorbent Assay in Quantitative Influenza Virus Culture

A. Osterhaus, G. Rimmelzwaan, E. van der Vries, 2014, Journal of Clinical Microbiology.

ViroSpot microneutralization assay for antigenic characterization of human influenza viruses.

M. Koopmans, G. Rimmelzwaan, R. Jeeninga, 2017, Vaccine.

Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef.

A. Osterhaus, J. Aerts, P. Lacor, 2008, Vaccine.

The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide

A. Hurt, D. Oh, Danielle Tilmanis, 2017, Antiviral research.

FATT‐CTL assay for detection of antigen‐specific cell‐mediated cytotoxicity

G. Rimmelzwaan, A. Osterhaus, E. Berkhoff, 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Human immunodeficiency virus type 1 (HIV-1)--and Epstein-Barr virus--specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1--infected persons.

A. Osterhaus, A. Geretti, J. Borleffs, 1996, The Journal of infectious diseases.

Simian immunodeficiency virus (SIV)-specific CD8+ cytotoxic T lymphocyte responses of naive and vaccinated cynomolgus macaques infected with SIVmac32H(J5): quantitative analysis by in vitro antigenic stimulation.

A. Osterhaus, G. van Amerongen, A. Geretti, 1997, Vaccine.

Uva-dare (digital Academic Repository) Human Immunodeficiency Virus Type 1 Rev-and Tat-specific Cytotoxic T Lymphocyte Frequencies Inversely Correlate with Rapid Progression to Aids

A. Geretti, R. Gruters, O. Pontesilli, 2022 .

Annual Vaccination against Influenza Virus Hampers Development of Virus-Specific CD8+ T Cell Immunity in Children

A. Osterhaus, H. Tiddens, G. Rimmelzwaan, 2011, Journal of Virology.

ViroSpot microneutralization assay for antigenic characterization of human influenza viruses.

M. Koopmans, G. Rimmelzwaan, R. Jeeninga, 2017, Vaccine.